What it sells
Non-invasive diagnostics.
Business model breakdown
Workflow: what inputs become what output?
Develops in-vitro diagnostic rapid point-of-care tests (RAPID POCT) using proprietary quantum-dot fluorescent materials for quantitative readout, from raw material to commercialization.
Economics: what it saves and how it charges
Diagnostics product developer; pre-Series A funding, MOU with Vietnam Nhat Minh Holdings for distribution.
Distribution: how it reaches customers
UnverifiedPartner/distributor MOUs (Vietnam); brochures and contact form.
Funding history and coverage
| Round date | Stage | Amount | Investors | Source |
|---|---|---|---|---|
| 2026-08-12 | Pre-Series A | — | Mineta Brook and others | news.google.com |
Profiles summarize public reporting and company websites. Business-model notes are MaxBC's reading of that material, not confirmed facts; unknowns are left blank rather than guessed. Updated 2026-10-12.